IDEAYA Biosciences Inc (NASDAQ:IDYA)
| 23.69 Delayed Data As of Aug 05 |  +0.39 / +1.67%Today’s Change | 11.00 Today|||52-Week Range 26.00 | +69.21% Year-to-Date |
Latest IDYA News | Press Releases
No recent news for IDEAYA Biosciences Inc.
Today’s Trading
| Previous close | 23.30 |
| Today’s open | 23.51 |
| Day’s range | 23.29 - 23.89 |
| Volume | 5,856 |
| Average volume (3 months) | 226,903 |
| Market cap | $917.9M |
Data as of 3:59pm ET, 08/05/2021
Growth & Valuation
| Earnings growth (last year) | +58.46% |
| Earnings growth (this year) | +22.04% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 17.71 |
| Price/Book | 3.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KNSAKiniksa Pharmaceutic... | +0.67 | +5.22% |
| EPIXESSA Pharma Inc | -0.25 | -1.16% |
| COLLCollegium Pharmaceut... | -0.10 | -0.40% |
| VNDAVanda Pharmaceutical... | +0.06 | +0.38% |
Data as of 4:08pm ET, 08/05/2021
Financials
| Next reporting date | August 17, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $19.5M |
| Annual profit (last year) | -$34.5M |
| Net profit margin | -176.55% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
